Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

ERBA Molecular Ltd Company Overview 4

ERBA Molecular Ltd Company Snapshot 4

ERBA Molecular Ltd Pipeline Products and Ongoing Clinical Trials Overview 4

ERBA Molecular Ltd – Pipeline Analysis Overview 7

ERBA Molecular Ltd - Key Facts 7

ERBA Molecular Ltd - Major Products and Services 8

ERBA Molecular Ltd Pipeline Products by Development Stage 9

ERBA Molecular Ltd Pipeline Products Overview 11

BART - HIV Viral Load Test 11

BART - HIV Viral Load Test Product Overview 11

Diagnostic Test - Campylobacter 12

Diagnostic Test - Campylobacter Product Overview 12

Diagnostic Test - E. coli 0157 13

Diagnostic Test - E. coli 0157 Product Overview 13

Diagnostic Test - H. Pylori 14

Diagnostic Test - H. Pylori Product Overview 14

Diagnostic Test - MRSA 15

Diagnostic Test - MRSA Product Overview 15

Diagnostic Test - Noro Virus 16

Diagnostic Test - Noro Virus Product Overview 16

Diagnostic Test - Salmonella 17

Diagnostic Test - Salmonella Product Overview 17

Early Infant Diagnostic Assay - HIV 18

Early Infant Diagnostic Assay - HIV Product Overview 18

Next Generation Fully Integrated Device 19

Next Generation Fully Integrated Device Product Overview 19

Next Generation HIV Viral Load Monitoring Test 20

Next Generation HIV Viral Load Monitoring Test Product Overview 20

Screening Assay - Malaria 21

Screening Assay - Malaria Product Overview 21

ERBA Molecular Ltd - Key Competitors 22

ERBA Molecular Ltd - Key Employees 23

ERBA Molecular Ltd - Locations And Subsidiaries 24

Head Office 24

Recent Developments 25

ERBA Molecular Ltd, Recent Developments 25

Feb 17, 2014: UNITAID Report Highlights Lumora’s Technology for Viral Load Monitoring for HIV 25

Appendix 26

Methodology 26

About GlobalData 29

Contact Us 29

Disclaimer 29

Summary

ERBA Molecular Ltd (ERBA Molecular), formerly Lumora Ltd, a subsidiary of Erba Diagnostics Mannheim GmbH, is a medical equipment company that offers innovative molecular diagnostics. The company provides technology that is used in medical diagnostics, agricultural, livestock and crops, food safety and pharmaceutical testing equipment, veterinary care products and personal care products. It also provides malaria diagnostic assay for screening patients, in-vitro diagnostics, and others. ERBA Molecular offers services such as bioinformatics, lyophilisation, testing, sample preparation, assay optimization, primer screening, commercial assay design programs, additional project support, and molecular test development process, among others. The company provides its products and services through its distributors located across the UK. ERBA Molecular is headquartered in Ely, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company ERBA Molecular Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company